Suppr超能文献

钙离子、磷脂和组织因子载脂蛋白对活化的因子 VII 激活人凝血因子 X 的作用。

The contributions of Ca2+, phospholipids and tissue-factor apoprotein to the activation of human blood-coagulation factor X by activated factor VII.

作者信息

Bom V J, Bertina R M

机构信息

Haemostasis and Thrombosis Research Unit, University Hospital Leiden, The Netherlands.

出版信息

Biochem J. 1990 Jan 15;265(2):327-36. doi: 10.1042/bj2650327.

Abstract

In the extrinsic pathway of blood coagulation, Factor X is activated by a complex of tissue factor, factor VII(a) and Ca2+ ions. Using purified human coagulation factors and a sensitive spectrophotometric assay for Factor Xa, we could demonstrate activation of Factor X by Factor VIIa in the absence of tissue-factor apoprotein, phospholipids and Ca2+. This finding allowed a kinetic analysis of the contribution of each of the cofactors. Ca2+ stimulated the reaction rate 10-fold at an optimum of 6 mM (Vmax. of 1.1 x 10(-3) min-1) mainly by decreasing the Km of Factor X (to 11.4 microM). In the presence of Ca2+, 25 microM-phospholipid caused a 150-fold decrease of the apparent Km and a 2-fold increase of the apparent Vmax. of the reaction; however, both kinetic parameters increased with increasing phospholipid concentration. Tissue-factor apoprotein contributed to the reaction rate mainly by an increase of the Vmax., in both the presence (40,500-fold) and absence (4900-fold) of phospholipid. The formation of a ternary complex of Factor VIIa with tissue-factor apoprotein and phospholipid was responsible for a 15 million-fold increase in the catalytic efficiency of Factor X activation. The presence of Ca2+ was absolutely required for the stimulatory effects of phospholipid and apoprotein. The data fit a general model in which the Ca2(+)-dependent conformation allows Factor VIIa to bind tissue-factor apoprotein and/or a negatively charged phospholipid surface resulting into a decreased intrinsic Km and an increased Vmax. for the activation of fluid-phase Factor X.

摘要

在血液凝固的外源性途径中,因子X被组织因子、因子VII(a)和钙离子的复合物激活。使用纯化的人凝血因子和一种用于因子Xa的灵敏分光光度测定法,我们能够证明在没有组织因子载脂蛋白、磷脂和钙离子的情况下,因子VIIa可激活因子X。这一发现使得对每个辅因子的作用进行动力学分析成为可能。钙离子在6 mM的最佳浓度下将反应速率提高了10倍(Vmax为1.1×10⁻³ min⁻¹),主要是通过降低因子X的Km(至11.4 μM)。在有钙离子存在的情况下,25 μM的磷脂使反应的表观Km降低了150倍,表观Vmax增加了2倍;然而,随着磷脂浓度的增加,这两个动力学参数均升高。组织因子载脂蛋白主要通过增加Vmax来促进反应速率,无论有无磷脂存在(有磷脂时增加40500倍,无磷脂时增加4900倍)。因子VIIa与组织因子载脂蛋白和磷脂形成的三元复合物使因子X激活的催化效率提高了1500万倍。磷脂和载脂蛋白的刺激作用绝对需要钙离子的存在。这些数据符合一个通用模型,其中钙离子依赖性构象使因子VIIa能够结合组织因子载脂蛋白和/或带负电荷的磷脂表面,并导致液相因子X激活的内在Km降低和Vmax增加。

相似文献

10
Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
Blood Cells Mol Dis. 2006 Mar-Apr;36(2):194-8. doi: 10.1016/j.bcmd.2005.12.032. Epub 2006 Mar 9.

引用本文的文献

1
Challenges with measuring tissue factor antigen and activity in human plasma.
Blood Vessel Thromb Hemost. 2024 Jul 31;1(4):100022. doi: 10.1016/j.bvth.2024.100022. eCollection 2024 Dec.
2
Comparative Efficacy of Recombinant FVIII and Recombinant FVII Biosimilars in Severe Hemophilia A.
Clin Appl Thromb Hemost. 2025 Jan-Dec;31:10760296251329329. doi: 10.1177/10760296251329329. Epub 2025 Mar 21.
3
Recombinant factor VIIa: new insights into the mechanism of action through product innovation.
Res Pract Thromb Haemost. 2024 Dec 31;9(1):102670. doi: 10.1016/j.rpth.2024.102670. eCollection 2025 Jan.
4
Modeling the distribution of enzymes on lipid vesicles: A novel framework for surface-mediated reactions in coagulation.
Math Biosci. 2024 Aug;374:109229. doi: 10.1016/j.mbs.2024.109229. Epub 2024 Jun 6.
5
Whole blood storage duration alters fibrinogen levels and thrombin formation.
J Trauma Acute Care Surg. 2024 Jul 1;97(1):39-47. doi: 10.1097/TA.0000000000004317. Epub 2024 Mar 27.
7
Tissue factor activity of small and large extracellular vesicles in different diseases.
Res Pract Thromb Haemost. 2023 Mar;7(3):100124. doi: 10.1016/j.rpth.2023.100124. Epub 2023 Mar 15.
8
The Tissue Factor Pathway in Cancer: Overview and Role of Heparan Sulfate Proteoglycans.
Cancers (Basel). 2023 Feb 28;15(5):1524. doi: 10.3390/cancers15051524.
10

本文引用的文献

1
Studies on the formation of the prothrombin-converting complex.
Biochem J. 1967 Mar;102(3):666-74. doi: 10.1042/bj1020666.
3
5
Binding of human factor VII and VIIa to monocytes.
J Clin Invest. 1982 Sep;70(3):526-35. doi: 10.1172/jci110644.
6
Preparation of beta-XIIa (Hageman factor fragment) from human plasma.
Thromb Res. 1982 Feb 15;25(4):307-17. doi: 10.1016/0049-3848(82)90231-6.
8
The physical significance of Km in the prothrombinase reaction.
Biochem Biophys Res Commun. 1983 Jul 29;114(2):526-32. doi: 10.1016/0006-291x(83)90812-4.
9
Purification and characterization of bovine tissue factor.
J Biol Chem. 1981 Aug 25;256(16):8324-31.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验